We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Physiomics Plc | LSE:PYC | London | Ordinary Share | GB00BDR6W943 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.05 | -3.33% | 1.45 | 1.40 | 1.50 | 1.50 | 1.45 | 1.50 | 92,556 | 08:10:16 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 597k | -477k | -0.0035 | -4.14 | 1.96M |
TIDMPYC
RNS Number : 8427V
Physiomics PLC
12 August 2020
12 August 2020
Physiomics plc
("Physiomics") or ("the Company")
Director Dealing
The Company announces that it received notice today that Dr Jim Millen sold 597,332 ordinary shares in the Company at 6.45p per share to cover the cost of his exercise of options announced on 5 August 2020.
Following the sale of shares, the total holdings of Dr Jim Millen will be 1,386,947, representing approximately 1.42 per cent. of the Company's issued share capital.
The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014.
Enquiries:
Physiomics plc
Dr Jim Millen, CEO
+44 (0)1865 784 980
Hybridan LLP (broker)
Claire Louise Noyce
+44 (0) 203 764 2341
Strand Hanson Ltd (NOMAD)
Richard Tulloch & James Dance
+44 (0)20 7409 3494
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1 Details of the person discharging managerial responsibilities/person closely associated a) Name James Millen --------------------------------------------------------------------- ------------------------- 2 Reason for the notification ------------------------------------------------------------------------------------------------ a) Position/status Director, CEO --------------------------------------------------------------------- ------------------------- b) Initial notification/ Amendment Initial notification --------------------------------------------------------------------- ------------------------- 3 Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor ------------------------------------------------------------------------------------------------ a) Name Physiomics plc --------------------------------------------------------------------- ------------------------- b) LEI 213800A71DSZ6ABMTQ91 --------------------------------------------------------------------- ------------------------- 4 Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted ------------------------------------------------------------------------------------------------ a) Description of the financial instrument, type of instrument Ordinary shares Identification code GB00BDR6W943 --------------------------------------------------------------------- ------------------------- b) Nature of the transaction Disposal of shares --------------------------------------------------------------------- ------------------------- c) Price(s) and volume(s) Price(s) Volume(s) 6.45p 597,332 ---------- --------------------------------------------------------------------- ------------------------- d) Aggregated information * Aggregated volume 597,332 At 6.45p per share * Price --------------------------------------------------------------------- ------------------------- e) Date of the transaction 11-8-2020 --------------------------------------------------------------------- ------------------------- f) Place of the transaction XLON, AIM --------------------------------------------------------------------- -------------------------
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHPBMRTMTJBBFM
(END) Dow Jones Newswires
August 12, 2020 02:00 ET (06:00 GMT)
1 Year Physiomics Chart |
1 Month Physiomics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions